Intravenous Immunoglobulin in Treating Nonventilated COVID-19 Patients With Moderate-to-Severe Hypoxia: A Pharmacoeconomic Analysis

  • 📰 Medscape
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 55%

United States Headlines News

United States Latest News,United States Headlines

This Visual Abstract pertains to an original research regarding intravenous immunoglobulin in treating nonventilated COVID patients with moderate-to-severe hypoxia. Read the rest here.

1. Galeotti C, Kaveri SV, Bayry J. IVIG-mediated effector functions in autoimmune and inflammatory diseases.2. Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.3. Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic.4. Shao Z, Feng Y, Zhong L, et al.

16. Liu X, Cao W, Li T. High-dose intravenous immunoglobulins in the treatment of severe acute viral pneumonia: the known mechanisms and clinical effects.17. Danieli MG, Piga MA, Paladini A, et al. Intravenous immunoglobulin as an important adjunct in prevention and therapy of coronavirus 19 disease.18. Starshinova A, Malkova A, Zinchenko U, et al. Efficacy of different types of therapy for COVID-19: a comprehensive review.19. Xiang HR, Cheng X, Li Y, Luo WW, Zhang QZ, Peng WX.

24. Rosas IO, Bräu N, Waters M, et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia.25. RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 : a randomised, controlled, open-label, platform trial.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Feeling Stressed Before You Get COVID May Increase Your Odds of Developing Long COVIDMillions of people are now suffering from long COVID, which presents with a staggering array of possible symptoms that can linger for months, or even years. What? Hey loser, this was your last strike. Unfollowed.
Source: ScienceAlert - 🏆 63. / 68 Read more »

If US Ends Public Health Emergency COVID Costs to Go Up for ManyVaccines, tests, and treatments will all cost more for various segments of the population; the uninsured will be hurt the most.
Source: Medscape - 🏆 386. / 55 Read more »

U.S. CDC director tests positive for COVID-19, experiencing mild symptomsThe director of the U.S. Centers for Disease Control and Prevention, Rochelle Walensky, tested positive for COVID-19 on Friday night and is experiencing mild symptoms, the CDC said in a statement on Saturday. say the line ABD CDC direktörü COVID-19'a karşı bulaşı önlemeyen ve korumayan aşıyı böyle savunuyor.! CDC direktörü 'AŞI SATIYOR'.!!! Aşı şirketleri.,COVID'den korumayan aşılarla'ORGANİZE SUÇ ÖRGÜTÜMÜ KURDULAR'.? Sure! Why not?
Source: Reuters - 🏆 2. / 97 Read more »

CDC’s Dr. Walensky tests positive for COVID-19Dr. Walensky, who is up-to-date with vaccination, is experiencing mild symptoms, the CDC said. 🤡🌎🤡🌎🤡🌎🤡🌎🤡🌎🤡🌎 🤣🤣🤣🤣
Source: FOX10Phoenix - 🏆 83. / 68 Read more »

Pfizer says Covid-19 vaccine list price could be $130 per dose once government contracts endDrugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its Covid-19 vaccine will be sold for $110 to $130 per dose. itsforyourhealth 🥴🥴 Heaven? Take my money💰💰💰💰💰💰💰💰💰 💰💰💰💰💰💰💰💰💰
Source: ABC7Chicago - 🏆 284. / 63 Read more »